Kapitalizacja Rynkowa Zmiana Data
AbbVie USD 384.69B 19.14B 2026-03
Agenus USD 107M 16M 2025-12
Amgen USD 189.89B 13.64B 2026-03
AstraZeneca USD 301.25B 13.1B 2026-03
Bristol-Myers Squibb USD 123.83B 14.02B 2026-03
Celldex Therapeutics USD 2.11B 307M 2026-03
CSL USD 55.89B 20.42B 2025-12
Eli Lilly USD 869.02B 146.97B 2026-03
Gilead Sciences USD 172.99B 20.71B 2026-03
GlaxoSmithKline GBP 83.8B 9.44B 2026-03
Incyte USD 18.73B 660M 2026-03
J&J USD 579.15B 78.91B 2026-03
Jiangsu Hengrui CNY 366.9B 29.67B 2026-03
Karyopharm Therapeutics USD 1.05B 912M 2026-06
Merck EUR 46.78B 6.52B 2026-03
Merck USD 297.1B 35.84B 2026-03
Northwest Biotherapeutics USD 270M 86M 2026-06
Novartis USD 307.76B 15.54B 2026-03
Novavax USD 1.09B 316M 2025-12
Pfizer USD 153.81B 12.24B 2026-03
Regeneron Pharmaceuticals USD 81.68B 560M 2026-03
Veracyte USD 2.57B 758M 2026-03